{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:53:04Z","timestamp":1758819184006,"version":"3.43.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1023\/a:1024431519652","type":"journal-article","created":{"date-parts":[[2003,9,15]],"date-time":"2003-09-15T13:22:37Z","timestamp":1063632157000},"page":"329-334","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of multiple recurrence events in superficial bladder cancer patients treated with intravesical bacillus Calmette-Gu\u00e9rin therapy using the Andersen-Gill's model"],"prefix":"10.1007","volume":"34","author":[{"given":"M.","family":"Takashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Wakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5119584_CR1","first-page":"273","volume-title":"Principles and Practice of Genitourinary Oncology","author":"HW Herr","year":"1997","unstructured":"Herr HW, Lamm DL, Denis L. Management of superficial bladder cancer. In: Raghavan D, Scher HI, Leibel SA, Lange P, eds. Principles and Practice of Genitourinary Oncology. Philadelphia: Lippincott-Raven, 1997: 273\u2013280."},{"issue":"Suppl.","key":"5119584_CR2","first-page":"18","volume":"26","author":"MS. Soloway","year":"1985","unstructured":"Soloway MS. Overview of treatment of superficial bladder cancer. Urology 1985; 26(Suppl.): 18\u201326.","journal-title":"Urology"},{"key":"5119584_CR3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0022-5347(17)49104-X","volume":"133","author":"JB deKernion","year":"1985","unstructured":"deKernion JB, Huang M, Lindner A et al. The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Gu\u00e9rin. J Urol 1985; 133: 598\u2013601.","journal-title":"J Urol"},{"key":"5119584_CR4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-5347(17)36197-9","volume":"149","author":"MD Melekos","year":"1993","unstructured":"Melekos MD, Chionis H, Pantazakos A et al. Intravesical bacillus Calmette-Gu\u00e9rin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule. J Urol 1993; 149: 744\u2013748.","journal-title":"J Urol"},{"key":"5119584_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02768242","volume":"26","author":"M Takashi","year":"1994","unstructured":"Takashi M, Kondo A, Nakano Y et ak. Total cystectomy after intravesical bacillus Calmette-Gu\u00e9rin (Tokyo strain) therapy for superficial bladder cancer: experience in Japan. Int Urol Nephrol 1994; 26: 33\u201342.","journal-title":"Int Urol Nephrol"},{"key":"5119584_CR6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1097-0142(19950115)75:2<552::AID-CNCR2820750219>3.0.CO;2-H","volume":"75","author":"H Akaza","year":"1995","unstructured":"Akaza H, Hinotsu S, Aso Y et al. Bacillus Calmette-Gu\u00e9rin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder: four-year results. Cancer 1995; 75: 552\u2013559.","journal-title":"Cancer"},{"key":"5119584_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1442-2042.1997.tb00160.x","volume":"4","author":"T Sinka","year":"1997","unstructured":"Sinka T, Matsumoto M, Ogura H et al. Recurrence of primary superficial bladder cancer treated with prophylactic intravesical Tokyo 172 bacillus Calmette-Gu\u00e9rin: a long term follow-up. Int J Urol 1997; 4: 139\u2013143.","journal-title":"Int J Urol"},{"key":"5119584_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF02552201","volume":"29","author":"M Takashi","year":"1997","unstructured":"Takashi M, Shimoji T, Murase T et al. Intravesical bacillus Calmette-Gu\u00e9rin (Tokyo 172 strain) therapy for carcinoma in situ of the bladder. Int Urol Nephrol 1997; 29: 557\u2013563.","journal-title":"Int Urol Nephrol"},{"key":"5119584_CR9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/BF02564859","volume":"30","author":"M Takashi","year":"1998","unstructured":"Takashi M, Katsuno S, Yuba H et al. Possible factors affecting response to intravesical bacillus Calmette-Gu\u00e9rin (Tokyo 172 starin) therapy for carcinoma in situ of the bladder: a multivariate analysis. Int Urol Nephrol 1998; 30: 713\u2013722.","journal-title":"Int Urol Nephrol"},{"key":"5119584_CR10","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.1987.5.12.2004","volume":"5","author":"LA Kalish","year":"1987","unstructured":"Kalish LA, Garnick MB, Richie JP. Appropriate endpoints for superficial bladder cancer clinical trials. J Clin Oncol 1987; 5: 2004\u20132008.","journal-title":"J Clin Oncol"},{"key":"5119584_CR11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0022-5347(05)65157-9","volume":"167","author":"MS Soloway","year":"2002","unstructured":"Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 2002: 167: 1573\u20131583.","journal-title":"J Urol"},{"key":"5119584_CR12","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","volume":"10","author":"PK Andersen","year":"1982","unstructured":"Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Ann Statist 1982; 10: 1100\u20131120.","journal-title":"Ann Statist"},{"key":"5119584_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1014444601158","volume":"33","author":"M Takashi","year":"2002","unstructured":"Takashi M, Wakai K, Hattori T et al. Multivariate evaluation of factors affecting recurrence, progression, and survival in patients with superficial bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin (Tokyo 172 strain) therapy: significance of concomitant carcinoma in situ. Int Urol Nephrol 2002; 33: 41\u201347.","journal-title":"Int Urol Nephrol"},{"key":"5119584_CR14","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-82982-6","volume-title":"UICC-International Union against Cancer TNM Classification of Malignant Tumours","author":"P Hermanek","year":"1987","unstructured":"Hermanek P, Sobin LH. UICC-International Union against Cancer TNM Classification of Malignant Tumours, 4th edn. Heidelberg: Springer Verlag, 1987.","edition":"4th edn."},{"key":"5119584_CR15","volume-title":"Atlas of Tumor Pathology","author":"LG. Koss","year":"1975","unstructured":"Koss LG. Tumors of the Urinary Bladder. Atlas of Tumor Pathology. 2nd ser., fasc. 11. Washington DC: Armed Forces Institute of Pathology, 1975."},{"key":"5119584_CR16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)37452-9","volume":"147","author":"HW Herr","year":"1992","unstructured":"Herr HW, Wartinger DD, Fair WR, Oettgen HF. Bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer: a 10-year followup. J Urol 1992; 147: 1020\u20131023.","journal-title":"J Urol"},{"key":"5119584_CR17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"5119584_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/biomet\/52.1-2.203","volume":"52","author":"EA. Gehan","year":"1965","unstructured":"Gehan EA. A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika 1965; 52: 203\u2013223.","journal-title":"Biometrika"},{"key":"5119584_CR19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"B34","author":"DR. Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc 1972; B34: 187\u2013220.","journal-title":"J R Stat Soc"},{"key":"5119584_CR20","first-page":"873","volume-title":"The PHREG procedure. SAS\/STAT Software: changes and enhancements through release 6.12","author":"SAS Institute Inc.","year":"1997","unstructured":"SAS Institute Inc. The PHREG procedure. SAS\/STAT Software: changes and enhancements through release 6.12. SAS Institute Inc. Cary, NC, 1997: 873\u2013948."},{"key":"5119584_CR21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","volume":"147","author":"DL Lamm","year":"1992","unstructured":"Lamm DL, van der Meijden APM, Morales A et al. Incidence and treatment of complications of bacillus Calmette-Gu\u00e9rin intravesical therapy in superficial bladder cancer. J Urol 1992; 147: 596\u2013600.","journal-title":"J Urol"},{"key":"5119584_CR22","first-page":"1094","volume-title":"Campbell's Urology","author":"WJ. Catalona","year":"1992","unstructured":"Catalona WJ. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr, eds. Campbell's Urology, 6th edn. Philadelphia: W.B. Saunders, 1992: 1094\u20131158.","edition":"6th edn."},{"key":"5119584_CR23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0022-5347(17)53725-8","volume":"127","author":"W Lutzeyer","year":"1982","unstructured":"Lutzeyer W, R\u00fcbben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982; 127: 250\u2013252.","journal-title":"J Urol"},{"key":"5119584_CR24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-5347(17)52330-7","volume":"129","author":"O Dalesio","year":"1983","unstructured":"Dalesio O, Schulman CC, Sylvester R et al. Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer, Genitourinary Tract Cancer Cooperative Group. J Urol 1983; 129: 730\u2013733.","journal-title":"J Urol"},{"key":"5119584_CR25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF02552138","volume":"27","author":"M Takashi","year":"1995","unstructured":"Takashi M, Wakai K, Ohno Y et al. Evaluation of a low-dose intravesical bacillus Calmette-Gu\u00e9rin (Tokyo strain) therapy for superficial bladder cancer. Int Urol Nephrol 1995; 27: 723\u2013733.","journal-title":"Int Urol Nephrol"},{"key":"5119584_CR26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/01621459.1989.10478873","volume":"84","author":"LJ Wei","year":"1989","unstructured":"Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84: 1065\u20131073.","journal-title":"J Am Stat Assoc"},{"key":"5119584_CR27","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.leu.2401242","volume":"12","author":"M Moos","year":"1998","unstructured":"Moos M, Schulz R, Martin S et al. The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma. Leukemia 1998; 12: 1971\u20131976.","journal-title":"Leukemia"},{"key":"5119584_CR28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.V1061309","volume":"10","author":"H Xia","year":"1999","unstructured":"Xia H, Ebben J, Ma JZ, Collins AJ. Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol 1999; 10: 1309\u20131316.","journal-title":"J Am Soc Nephrol"},{"key":"5119584_CR29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0035-9203(00)90218-9","volume":"94","author":"HA Giha","year":"2000","unstructured":"Giha HA, Rosthoj S, Dodoo D et al. The epidemiology of febrile malaria episodes in an area of unstable and seasonal transmission. Trans R Soc Trop Med Hyg 2000; 94: 645\u2013651.","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024431519652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1024431519652\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024431519652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:45:32Z","timestamp":1754891132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1024431519652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["5119584"],"URL":"https:\/\/doi.org\/10.1023\/a:1024431519652","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}